Sign In  |  Register  |  About Santa Clara  |  Contact Us

Santa Clara, CA
September 01, 2020 1:39pm
7-Day Forecast | Traffic

  • Search Hotels in Santa Clara

  • CHECK-IN:
  • CHECK-OUT:
  • ROOMS:
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Elevai Labs, Inc. - Common Stock (NQ: ELAB )

0.0205 -0.0009 (-4.21%)
Streaming Delayed Price Updated: 1:51 PM EST, Nov 21, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 200,760,657
Open 0.0209
Bid (Size) 0.0205 (1,575)
Ask (Size) 0.0206 (531)
Prev. Close 0.0214
Today's Range 0.0200 - 0.0209
52wk Range 0.0161 - 4.244
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
CORRECTION - Elevai Labs Inc.
From Elevai Labs Inc.
Via GlobeNewswire
US Stocks Edge Lower; Cisco Earnings Top Views
Via Benzinga

Performance

YTD
-98.92%
-98.92%
1 Month
-79.29%
-79.29%
3 Month
-91.09%
-91.09%
6 Month
-96.92%
-96.92%
1 Year
-99.40%
-99.40%

More News

Read More
Elevai Labs Inc. Reports Financial Results for the Second Fiscal Quarter of 2024 and Provides Business Update
From Elevai Labs Inc.
Via GlobeNewswire
Why DLocal Shares Are Trading Higher By Around 18%; Here Are 20 Stocks Moving Premarket
Via Benzinga
MicroCaps Making Major Moves: DJT, BNOX, ELAB, PETV, RJDG in High-Growth Markets
Via AB Newswire
Topics Government
Exposures Political
Why Palantir Shares Are Trading Higher By Around 13%; Here Are 20 Stocks Moving Premarket
Via Benzinga
Elevai Labs Inc. Announces Update and Extension of Pending Offer to Exchange
From Elevai Labs Inc.
Via GlobeNewswire
Dow Jumps 400 Points; US Adds 12,000 Jobs In October
Via Benzinga
Topics Stocks
Exposures US Equities
Why Charter Communications Shares Are Trading Higher By Around 11%; Here Are 20 Stocks Moving Premarket
Via Benzinga
Why Carvana Shares Are Trading Higher By Around 20%; Here Are 20 Stocks Moving Premarket
Via Benzinga
12 Consumer Staples Stocks Moving In Friday's Intraday Session
Via Benzinga
Elevai Biosciences, a Subsidiary of Elevai Labs Inc., Engages Leading Contract Research Organization (CRO) to Support Regulatory Planning Efforts and Pre-IND Meeting with the Food and Drug Administration For EL-22 For The Treatment of Obesity
From Elevai Labs Inc.
Via GlobeNewswire
Elevai Biosciences, a Subsidiary of Elevai Labs Inc., Highlights Past Positive Preclinical Data Showing Potential of EL-32, A Dual Myostatin & Activin-A Blocker, For the Treatment of Obesity
From Elevai Labs Inc.
Via GlobeNewswire
12 Consumer Staples Stocks Moving In Thursday's After-Market Session
Via Benzinga
Elevai Labs Inc. Commences Offer to Exchange Up to 15,000,000 shares of Common Stock For Shares of Non Tradable. Locked Up Series B Preferred Stock
From Elevai Labs Inc.
Via GlobeNewswire
12 Consumer Staples Stocks Moving In Friday's After-Market Session
Via Benzinga
11 Consumer Staples Stocks Moving In Friday's Intraday Session
Via Benzinga
Why Phoenix Motor Shares Are Trading Higher By 150%; Here Are 20 Stocks Moving Premarket
Via Benzinga
12 Consumer Staples Stocks Moving In Thursday's After-Market Session
Via Benzinga
REPEAT: Elevai Biosciences, a Subsidiary of Elevai Labs Inc., Expands Patent Portfolio with Two New Filings for EL-22 in Muscle Loss Treatment for Obese Patients, Including GLP-1 Receptor Agonist Combinations
From Elevai Labs Inc.
Via GlobeNewswire
Nasdaq Moves Lower; Levi Strauss Shares Slide
Via Benzinga
Crude Oil Jumps Over 4%; US Services PMI Revised Lower
Via Benzinga
Exposures Fossil Fuels
Dow Dips Over 100 Points; US Jobless Claims Increase To 225,000
Via Benzinga
Topics Stocks
Exposures US Equities
12 Consumer Staples Stocks Moving In Thursday's Pre-Market Session
Via Benzinga
Elevai Biosciences, a Subsidiary of Elevai Labs Inc., Expands Patent Portfolio with Two New Filings for EL-22 in Muscle Loss Treatment for Obese Patients, Including GLP-1 Receptor Agonist Combinations
From Elevai Labs Inc.
Via GlobeNewswire
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
 
 
About Us | Contact Us | Privacy Policy | User Agreement | Advertise With Us | Site Map
Copyright © 2010-2020 SantaClara.com & California Media Partners, LLC. All rights reserved.